| [1] | Yanhong YE, Lijian LU. Current research status of Gd-EOB-DTPA-enhanced MRI in evaluating liver reserve function in residual liver tissue after liver tumor surgery[J]. Journal of Clinical Hepatology, 2024, 40(2): 380-385. doi: 10.12449/JCH240226 |
| [2] | Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018 |
| [3] | Zhao LI, Jiye ZHU. Interpretation of guidelines for the diagnosis and treatment of primary liver cancer （2024 edition）[J]. Journal of Clinical Hepatology, 2024, 40(7): 1324-1327. doi: 10.12449/JCH240707 |
| [4] | National Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer （2024 edition）[J]. Journal of Clinical Hepatology, 2024, 40(5): 893-918. doi: 10.12449/JCH240508 |
| [5] | Branch of Hepatobiliary Diseases， China Association of Chinese Medicine. Guideline for traditional Chinese medicine diagnosis and treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2024, 40(5): 919-927. doi: 10.12449/JCH240509 |
| [6] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
| [7] | ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006 |
| [8] | Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042 |
| [9] | Prevention of Infection Related Cancer (PIRCA) Group, Specialized Committee of Cancer Prevention and Control, Chinese Preventive Medicine Association, Non-communicable & Chronic Disease Control and Prevention Society, Chinese Preventive Medicine Association, Health Communication Society, Chinese Preventive Medicine Association. Strategies of primary prevention of liver cancer in China: Expert Consensus ( 2018)[J]. Journal of Clinical Hepatology, 2018, 34(10): 2090-2097. doi: 10.3969/j.issn.1001-5256.2018.10.008 |
| [10] | Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033 |
| [11] | Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014 |
| [12] | Li Zhao, Zhu JiYe. An interpretation of diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. Journal of Clinical Hepatology, 2017, 33(9): 1655-1657. doi: 10.3969/j.issn.1001-5256.2017.09.006 |
| [13] | National Health and Family Planning Commission of the People’s Republic of China;. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. Journal of Clinical Hepatology, 2017, 33(8): 1419-1431. doi: 10.3969/j.issn.1001-5256.2017.08.003 |
| [14] | Huang Cheng, Sun HuiChuan. EASL clinical practice guidelines on the management of benign liver tumors (2016)[J]. Journal of Clinical Hepatology, 2016, 32(8): 1439-1445. doi: 10.3969/j.issn.1001-5256.2016.08.001 |
| [15] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
| [16] | Fan Jia, Pan Qi, Shi YingHong. Comparison of diagnostic and treatment algorithm of America, Asia-Pacific and China for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(4): 346-347+364. |
| [17] | Chinese Society of Liver Cancer (CSLC), Chinese Society of Clinical Oncology(CSCO), Liver Cancer Group, Chinese Society of Hepatology, The National Cooperative Group on Hepatic Tumors and Transplantation Pathology. Experts consensus on pathological diagnosis of primary liver cancer[J]. Journal of Clinical Hepatology, 2011, 27(4): 343-345. |
| [19] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |
DownLoad: